This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mesco Pharmaceuticals Widens Net Loss in Fiscal Q3 MT
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Mesco Pharmaceuticals Limited Announces Resignation of Savita Sethi as Independent Director CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as Chief Executive Officer CI
Mesco Pharmaceuticals Limited Appoints Dhruv Singh as an Additional Director on the Board of the Company CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Mesco Pharmaceuticals Limited Announces Demise of Jitendra Kumar Singh, Non-Executive and Non Independent Director CI
Mesco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Mesco Pharmaceuticals Limited Appoints Hawa Singh Chahar as an Additional Director (Non-Executive Independent Director) CI
Mesco Pharmaceuticals Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019 CI
Mesco Pharmaceuticals Limited Appoints Varinder Prakash as an Additional Director CI
Mesco Pharmaceuticals Announces Management Changes CI
Mesco Pharmaceuticals Limited Announces Resignation of Subash Chander Seth as Non-Executive, Independent Director CI
Mesco Pharmaceuticals Limited Announces Change in Management CI
Mesco Pharmaceuticals Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended December 31, 2018 CI
Mesco Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
Mesco Pharmaceuticals Ltd Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2018 CI
Mesco Pharmaceuticals Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018 CI
Mesco Pharmaceuticals Ltd Announces Management Changes CI
Chart Mesco Pharmaceuticals Limited
More charts
  1. Stock Market
  2. Equities
  3. 500274 Stock
  4. News Mesco Pharmaceuticals Limited
  5. Mesco Pharmaceuticals Widens Net Loss in Fiscal Q3